IFIH1 and dermatomyositis: In contrast, anti-MDA5 antibodies are detected in patients with dermatomyositis (DM) or amyopathic dermatomyositis (ADM), who are often complicated with rapidly progressive ILD (RP-ILD), which is associated with early mortality [8].